BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu XJ, Yu F, Song D, Wang SX, Song Y, Liu G, Zhao MH. Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China. ScientificWorldJournal 2014;2014:680502. [PMID: 25184151 DOI: 10.1155/2014/680502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Navarro D, Azevedo A, Sequeira S, Ferreira AC, Carvalho F, Fidalgo T, Vilarinho L, Santos MC, Calado J, Nolasco F. Atypical adult-onset methylmalonic acidemia and homocystinuria presenting as hemolytic uremic syndrome. CEN Case Rep 2018;7:73-6. [PMID: 29294253 DOI: 10.1007/s13730-017-0298-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Song D, Liu X, Chen Z, Xiao H, Ding J, Sun S, Liu H, Guo W, Wang S, Yu F, Zhao M; On Behalf of the Chinese Renal–TMA Network Institutes. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome. Pediatr Nephrol 2017;32:811-22. [DOI: 10.1007/s00467-016-3562-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
3 Bae MN, Kwak DH, Park SJ, Choi BS, Park CW, Choi YJ, Lee JW, Yang CW, Kim YS, Chung BH. Acute kidney injury induced by thrombotic microangiopathy in a patient with hemophagocytic lymphohistiocytosis. BMC Nephrol 2016;17:4. [PMID: 26739581 DOI: 10.1186/s12882-015-0217-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
4 Kraft S, Bollinger N, Bodenmann B, Heim D, Bucher C, Lengerke C, Kleber M, Tsakiris DA, Passweg J, Tzankov A, Medinger M. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease. Bone Marrow Transplant 2019;54:540-8. [DOI: 10.1038/s41409-018-0293-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
5 Haridasan S, Priyamvada PS, Puthiyottil D, Pradeep A, Parameswaran S, Srinivas BH, Ganesh RN. Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study. Indian J Nephrol 2021;31:467-73. [PMID: 34880557 DOI: 10.4103/ijn.IJN_187_20] [Reference Citation Analysis]
6 Larsen CP, Wilson JD, Best-Rocha A, Beggs ML, Hennigar RA. Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy. Mod Pathol 2018;31:488-94. [PMID: 29148534 DOI: 10.1038/modpathol.2017.154] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
7 Liang S, Le W, Liang D, Chen H, Xu F, Chen H, Liu Z, Zeng C. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study. BMC Nephrol 2016;17:42. [PMID: 27066888 DOI: 10.1186/s12882-016-0254-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
8 Li C, Yap DY, Chan G, Wen Y, Li H, Tang C, Li X, Li X, Chan TM. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy. J Rheumatol 2019;46:1478-84. [DOI: 10.3899/jrheum.180773] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
9 Nishi K, Sato M, Ogura M, Okutsu M, Ishikura K, Kamei K. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy. BMC Nephrol 2020;21:323. [PMID: 32746791 DOI: 10.1186/s12882-020-01985-5] [Reference Citation Analysis]
10 Guo HY, Sun J, Su Y, Zhang Q, Hua R, Xia X, Fang D. Thrombotic microangiopathy led to acute kidney injury in an infant with hemophagocytic lymphohistiocytosis: A case report. Exp Ther Med 2021;21:396. [PMID: 33680118 DOI: 10.3892/etm.2021.9827] [Reference Citation Analysis]
11 Teixeira CM, Tedesco Silva Junior H, Moura LAR, Proença HMS, de Marco R, Gerbase de Lima M, Cristelli MP, Viana LA, Felipe CR, Medina Pestana JO. Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes. PLoS One 2020;15:e0227445. [PMID: 31923282 DOI: 10.1371/journal.pone.0227445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zuckerman JE, Chang A. Complement and Renal Thrombotic Microangiopathy Associated With Hypertension and Scleroderma. Adv Chronic Kidney Dis 2020;27:149-54. [PMID: 32553247 DOI: 10.1053/j.ackd.2019.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cai Q, Shi S, Wang S, Ren Y, Hou W, Liu L, Lv J, Haas M, Zhang H. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study. American Journal of Kidney Diseases 2019;74:629-39. [DOI: 10.1053/j.ajkd.2019.03.416] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
14 Chen SF, Wang H, Huang YM, Li ZY, Wang SX, Yu F, Zhao MH, Chen M. Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin J Am Soc Nephrol 2015;10:750-8. [PMID: 25749534 DOI: 10.2215/CJN.07910814] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
15 Ormonde C, Querido S, Rombo N, Roque R, Clemente B, Weigert A. Primary Hyperaldosteronism: A Rare Cause of Malignant Hypertension with Thrombotic Microangiopathy in a Kidney Transplant Recipient. Case Rep Transplant 2021;2021:9261371. [PMID: 34820145 DOI: 10.1155/2021/9261371] [Reference Citation Analysis]
16 Cavero T, Arjona E, Soto K, Caravaca-fontán F, Rabasco C, Bravo L, de la Cerda F, Martín N, Blasco M, Ávila A, Huerta A, Cabello V, Jarque A, Alcázar C, Fulladosa X, Carbayo J, Anaya S, Cobelo C, Ramos N, Iglesias E, Baltar J, Martínez-gallardo R, Pérez L, Morales E, González R, Macía M, Draibe J, Pallardó L, Quintana LF, Espinosa M, Barros X, Pereira F, Cao M, Moreno JA, Rodríguez de Córdoba S, Praga M. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome. Kidney International 2019;96:995-1004. [DOI: 10.1016/j.kint.2019.05.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]